Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 2/6 |
Ilsung Is Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₩18,380.00 |
52 Week High | ₩29,000.00 |
52 Week Low | ₩18,000.00 |
Beta | -0.21 |
11 Month Change | -1.13% |
3 Month Change | -6.70% |
1 Year Change | -24.36% |
33 Year Change | 11.39% |
5 Year Change | 4.67% |
Change since IPO | 1,109.22% |
Recent News & Updates
Recent updates
Reflecting on Ilsung Pharmaceuticals' (KRX:003120) Share Price Returns Over The Last Three Years
Feb 20Ilsung Pharmaceuticals (KRX:003120) Is Growing Earnings But Are They A Good Guide?
Jan 16Here's What Ilsung Pharmaceuticals Co., Ltd.'s (KRX:003120) Shareholder Ownership Structure Looks Like
Dec 18Reflecting on Ilsung Pharmaceuticals' (KRX:003120) Share Price Returns Over The Last Three Years
Nov 21Shareholder Returns
A003120 | KR Pharmaceuticals | KR Market | |
---|---|---|---|
7D | -0.2% | -1.7% | -3.7% |
1Y | -24.4% | 14.6% | 2.4% |
Return vs Industry: A003120 underperformed the KR Pharmaceuticals industry which returned 14.6% over the past year.
Return vs Market: A003120 underperformed the KR Market which returned 2.4% over the past year.
Price Volatility
A003120 volatility | |
---|---|
A003120 Average Weekly Movement | 1.2% |
Pharmaceuticals Industry Average Movement | 3.8% |
Market Average Movement | 5.0% |
10% most volatile stocks in KR Market | 11.1% |
10% least volatile stocks in KR Market | 2.2% |
Stable Share Price: A003120 has not had significant price volatility in the past 3 months.
Volatility Over Time: A003120's weekly volatility (1%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1954 | n/a | Seok-geun Yoon | www.ilsung-ph.co.kr |
Ilsung Is Co., Ltd. operates as a pharmaceutical company in South Korea. Its products include antibiotics, analgesics, muscle relaxants, antipyretic-analgesics, antihistamine, neuropsychiatric, neuromuscular blocker/ central muscle relaxants, anti-coagulants, probiotics, vaccine, medical equipment, circulatory system drugs, contrast agents, muscle relaxants, diabetes treatments, osteopathic, digestive system medicines, anti-virals, anti-emetics, respiratory treatments, adrenal cortical steroids, anesthetics, antipyretics, and cardiovascular system products. The company was formerly known as Ilsung Pharmaceuticals Co., Ltd.
Ilsung Is Co., Ltd. Fundamentals Summary
A003120 fundamental statistics | |
---|---|
Market cap | ₩128.09b |
Earnings (TTM) | -₩16.53b |
Revenue (TTM) | ₩76.11b |
1.7x
P/S Ratio-7.8x
P/E RatioIs A003120 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
A003120 income statement (TTM) | |
---|---|
Revenue | ₩76.11b |
Cost of Revenue | ₩42.58b |
Gross Profit | ₩33.53b |
Other Expenses | ₩50.05b |
Earnings | -₩16.53b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -2.37k |
Gross Margin | 44.05% |
Net Profit Margin | -21.72% |
Debt/Equity Ratio | 0% |
How did A003120 perform over the long term?
See historical performance and comparison